Lee's Pharmaceutical Holdings Limited

Informe acción SEHK:950

Capitalización de mercado: HK$694.8m

Salud financiera de hoja de balance de Lee's Pharmaceutical Holdings

Salud financiera controles de criterios 5/6

Lee's Pharmaceutical Holdings tiene un patrimonio de accionistas total de HK$2.0B y una deuda total de HK$192.8M, lo que sitúa su ratio deuda-patrimonio en 9.8%. Sus activos y pasivos totales son HK$2.9B y HK$930.1M respectivamente. El BAIT de Lee's Pharmaceutical Holdings es de HK$36.0M, por lo que su ratio de cobertura de intereses es de 3.7. Tiene efectivo e inversiones a corto plazo que ascienden a HK$171.0M.

Información clave

9.8%

Ratio deuda-patrimonio

HK$192.76m

Deuda

Ratio de cobertura de intereses3.7x
EfectivoHK$171.00m
PatrimonioHK$1.96b
Total pasivoHK$930.07m
Activos totalesHK$2.89b

Actualizaciones recientes sobre salud financiera

Recent updates

Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Dec 20
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Apr 02
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Aug 29
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Apr 05
Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Mar 17
Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

Feb 22
Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 29
What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Jan 12
What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?

Dec 22
Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Lee's Pharmaceutical Holdings Limited (HKG:950)

Dec 08
Don't Ignore The Fact That This Insider Just Sold Some Shares In Lee's Pharmaceutical Holdings Limited (HKG:950)

Is Lee's Pharmaceutical Holdings Limited's (HKG:950) Recent Price Movement Underpinned By Its Weak Fundamentals?

Dec 01
Is Lee's Pharmaceutical Holdings Limited's (HKG:950) Recent Price Movement Underpinned By Its Weak Fundamentals?

Is Lee's Pharmaceutical Holdings Limited (HKG:950) A Strong Dividend Stock?

Nov 18
Is Lee's Pharmaceutical Holdings Limited (HKG:950) A Strong Dividend Stock?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (HK$656.6M) de 950 superan a sus pasivos a corto plazo (HK$648.8M).

Pasivo a largo plazo: Los activos a corto plazo de 950 (HK$656.6M) superan a sus pasivos a largo plazo (HK$281.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (1.1%) de 950 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 950 ha crecido de 5.8% a 9.8% en los últimos 5 años.

Cobertura de la deuda: La deuda de 950 está bien cubierta por el flujo de caja operativo (57.1%).

Cobertura de intereses: Los pagos de intereses de la deuda de 950 están bien cubiertos por el BAIT (3.7x cobertura).


Hoja de balance


Descubre empresas con salud financiera